Li Dan, Long Yu, Yu Shuang, Shi Ai, Wan Jinyan, Wen Jing, Li Xiaoqiu, Liu Songyu, Zhang Yulu, Li Nan, Zheng Chuan, Yang Ming, Shen Lin
State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Front Pharmacol. 2022 Jan 31;12:832673. doi: 10.3389/fphar.2021.832673. eCollection 2021.
Cardio-cerebrovascular diseases (CVDs) are a serious threat to human health and account for 31% of global mortality. Hort. (CX) is derived from umbellifer plants. Its rhizome, leaves, and fibrous roots are similar in composition but have different contents. It has been used in Japanese, Korean, and other traditional medicine for over 2000 years. Currently, it is mostly cultivated and has high safety and low side effects. Due to the lack of a systematic summary of the efficacy of CX in the treatment of CVDs, this article describes the material basis, molecular mechanism, and clinical efficacy of CX, as well as its combined application in the treatment of CVDs, and has been summarized from the perspective of safety. In particular, the pharmacological effect of CX in the treatment of CVDs is highlighted from the point of view of its mechanism, and the complex mechanism network has been determined to improve the understanding of CX's multi-link and multi-target therapeutic effects, including anti-inflammatory, antioxidant, and endothelial cells. This article offers a new and modern perspective on the impact of CX on CVDs.
心脑血管疾病(CVDs)对人类健康构成严重威胁,占全球死亡率的31%。川芎(CX)源自伞形科植物。其根茎、叶子和须根成分相似但含量不同。它在日本、韩国和其他传统医学中已使用了2000多年。目前,它大多为人工种植,安全性高且副作用低。由于缺乏对川芎治疗心脑血管疾病疗效的系统总结,本文阐述了川芎的物质基础、分子机制、临床疗效,以及其在治疗心脑血管疾病中的联合应用,并从安全性角度进行了总结。特别是,从机制角度突出了川芎治疗心脑血管疾病的药理作用,并确定了复杂的机制网络,以增进对川芎多环节、多靶点治疗作用的理解,包括抗炎、抗氧化和对内皮细胞的作用。本文为川芎对心脑血管疾病的影响提供了一个全新的现代视角。